Questions about our company

  • When was the stock listed?

    The stock was listed on the Growth Market of the Tokyo Stock Exchange on Jun. 14, 2024.

  • I'd like to know what your company does.

    Chordia Therapeutics engages in drug discovery specializing in oncology with high unmet medical needs, as well as in the research and development of first-in-class small-molecule pharmaceuticals with novel, unprecedented mechanisms of action. 

Questions about our financial results, business performance, and IR

Questions about our stock